Work

NICE recommends mirikizumab as a treatment option for Crohn's disease

Year: 2025

Type: article

Source: Pharmaceutical journal/The pharmaceutical journal

DOI: 10.1211/pj.2025.1.360489

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4411229232

FWCI:

Cites:

Cited by:

Related to: 10